Log in to save to my catalogue

Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐rela...

Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐rela...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_253d934b0fa14eca9e41eee1ebbe2db1

Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting

About this item

Full title

Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Journal of cachexia, sarcopenia and muscle, 2021-06, Vol.12 (3), p.731-745

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Skeletal muscle wasting (SMW) in cancer patients is associated with increased morbidity, mortality, treatment intolerance and discontinuation, and poor quality of life. This is particularly true for patients with pancreatic ductal adenocarcinoma (PDAC), as over 85% experience SMW, which is responsible for ~30% of patient deaths. While...

Alternative Titles

Full title

Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_253d934b0fa14eca9e41eee1ebbe2db1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_253d934b0fa14eca9e41eee1ebbe2db1

Other Identifiers

ISSN

2190-5991

E-ISSN

2190-6009

DOI

10.1002/jcsm.12699

How to access this item